Home - X4 Pharmaceuticals

With grit and integrity, we advance novel therapies for individuals with chronic neutropenic disorders. The page tagline says, “Progress for Patients” over an image of the sun rising behind Half Dome in Yosemite National Park. There is a button to "learn more" that directs to the website’s Focus page.

PROGRESS

PATIENTS

Enabling a better future for people with rare immune disorders

recent news

X4 Pharmaceuticals to Participate in the Stifel 2024 Healthcare Conference
November 14, 2024
X4 Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Corporate Update
November 13, 2024
X4 Pharmaceuticals Announces Positive Results from Completed Six-Month Phase 2 Trial of Mavorixafor in Chronic Neutropenia (CN)
November 13, 2024

© Copyright 2024 X4 Pharmaceuticals. All Rights Reserved. Terms of Use | Privacy | Compliance and Ethics